mynth
← DATABASE
09/2026Majority

Nextstage takes majority stake in Domaine de Chezelles

FRANCE Food Processing / Food Products REV €25–50M

Context

Financed via a direct equity injection of approximately 26 million euros, the leveraged buyout orchestrated by NextStage AM secures majority control of Domaine de Chezelles to support its transmission and digital transformation. Announced in September 2026, this strategic Management Buy-In (MBI) officially transitions the apitherapy specialist away from its historical generational ownership structure. The financial architecture of the transaction deploys capital specifically from the NextStage Evergreen vehicle and the Capital Entrepreneur funds. Under the newly configured capitalization table, incoming executive Karen Vernet assumes the role of President, taking over operational leadership from the outgoing family representative, Marie-Cécile Hernaez. Concurrently with the majority stake purchase by NextStage AM, Marie-Cécile Hernaez executed a strategic reinvestment to maintain a minority equity position alongside the new leadership, ensuring continuity of the brand's historical heritage. The strategic rationale driving NextStage AM centers on scaling the authentic heritage of the brand to capture market share within the rapidly expanding natural dietary supplements and functional foods sector. The newly injected institutional capital is explicitly earmarked to finance an aggressive omnichannel expansion strategy, aggressively pushing the commercial footprint beyond its historical direct sales network while significantly upgrading its digital infrastructure and scientific credibility. The integration roadmap relies on the extensive retail and digital transformation expertise of Karen Vernet, drawing on her previous executive tenure at the Printemps group and Ecotone.

By taking control of Domaine de Chezelles, Nextstage continues its expansion strategy. Previously, the group had completed 3 acquisitions, including Société des Eaux Minérales D’arcachon in 2026.

Domaine de Chezelles, which reported an EBITDA margin of [members only] in 2025, is valued in this transaction at an EV/EBITDA multiple of [members only].

-> Deep-dive in AgriFood market trends

Target

Founded in 1900 in Chezelles within the Berry region of France, Domaine de Chezelles develops, manufactures, and directly distributes natural apitherapy products and specialized dietary supplements. Built upon more than 125 years of generational beekeeping expertise, the French enterprise operates as a specialist in the extraction and valorization of hive products, specifically focusing on fresh royal jelly, propolis, pollen, and honey. The brand systematically integrates these active natural ingredients into a comprehensive product portfolio encompassing approximately fifty distinct references of natural dietary supplements targeting immunity, sleep, joint health, digestion, and memory support, alongside a dedicated range of apitherapy-based cosmetics. To distribute its natural health formulations, the domain relies heavily on a direct sales model, fostering close, long-term commercial relationships with a loyal customer base. The manufacturing model prioritizes rigorous raw material selection, complete traceability, and long-term partnerships with established producers to maintain artisanal quality standards in the preservation of living hive materials.

Ent. Value

[members only]

Equity Value

[members only]

Multiples

EV / Revenue

[members only]

EV / EBITDA

[members only]

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2025
€25–50M
[members only]
[members only]
2024
€25–50M
[members only]
[members only]

Other operations with Nextstage

Other operations with Nextstage
DateAcquirerTargetCountrySector
10/2026NEXTSTAGECORAVIAFRANCEMedical Consumables
09/2026NEXTSTAGE / SOCADIFGROUPE PIERRE YOVANOVITCHFRANCEHigh-End Lifestyle
03/2026NEXTSTAGESOCIÉTÉ DES EAUX MINÉRALES D’ARCACHON (SEMA)FRANCESoft Drinks
02/2026NEXTSTAGEEMARGENCEFRANCEAccounting & Audit
12/2024NEXTSTAGE / IK PARTNERSEUROBIO SCIENTIFICFRANCEDiagnostic Equipment
10/2024NEXTSTAGEPEERSGROUPFRANCEStrategy & Management
04/2019NEXTSTAGE / MI3GROUPE BAGATELLEFRANCERestaurants / Chains

Similar deals in Food Processing

Similar deals in Food Processing
DateAcquirerTargetCountrySector
10/2026FLEURY MICHONALL PLANTSUNITED KINGDOMFood Products
10/2026CALIFORNIA CUSTOM FRUITS & FLAVORSSKJODT-BARRETT INGREDIENTSCANADAIngredients
09/2026SAZERACBERENTZENGERMANYWines & Spirits
09/2026GRUPO LUSIAVESPAVO Y DERIVADOSSPAINMeat & Cured Meat
09/2026EUROPEAN PIZZA GROUP (EPG)CROSTA MOLLICAUNITED KINGDOMFood Products
09/2026AURELIUSHAIN INTERNATIONALUNITED KINGDOMFood Products
09/2026HORMEL FOODSBRAKEBUSHUNITED STATESMeat & Cured Meat
09/2026C.H. GUENTHER & SONHOUSE-AUTRY MILLSUNITED STATESIngredients
09/2026IDIA CAPITAL INVESTISSEMENT / SOFIPACAMIRAVAL PROVENCEFRANCEWines & Spirits
09/2026CREDIT MUTUEL EQUITYVAN DEN CASTEELEFRANCEDairy

REFERENCES

Revenue range: REV €25–50M

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Domaine de Chezelles by Nextstage are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: domaine de chezelles

FAQ

What transaction does this page cover?

This page covers the acquisition of a majority stake in Domaine de Chezelles, a French company specialised in Food Products, by Nextstage in 2026.

What was Domaine de Chezelles’s revenue at the time of the deal?

At the time of the transaction, Domaine de Chezelles’s annual revenue was estimated within the €25–50M range (FY 2025). Detailed financial figures are available to members.

What sources support the information on this transaction?

Information on this transaction is sourced from the official corporate announcement published by the parties, corroborated by a private document shared by the community and verified by the mynth team to ensure the accuracy of the shared information.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.